Follow the people · Insider
Adam Taich
Adam Taich files insider transactions with the SEC as a chief financial officer of 10x Genomics (TXG). We hold 3 disclosed purchases and sales filed since 12 June 2023, 1 of them in the last 90 days.
- Files forTXG
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure26 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 23 October 2024 — 24 August 2026Chief Financial Officer · 10x Genomics (TXG)11 Form 4 lines · source: SEC Form 4
- Filed 2 March 2023 — 5 January 2024Interim CEO · SomaLogic (SLGC)16 Form 4 lines · source: SEC Form 4
Everything they disclosed
27 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 17,166 shares of 10x GenomicsSEC Form 426 August 2026Class A Common Stock · traded 24 August 2026 · filed 26 August 2026
- ▼ sold on the open market 15,098 shares of 10x GenomicsSEC Form 427 May 2026Class A Common Stock · traded 22 May 2026 · filed 27 May 2026
- was granted 106,579 shares of 10x GenomicsSEC Form 42 March 2026Class A Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 106,579 shares of 10x GenomicsSEC Form 42 March 2026Class A Common Stock · traded 26 February 2026 · filed 2 March 2026
- ▼ sold on the open market 8,968 shares of 10x GenomicsSEC Form 425 February 2026Class A Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 8,968 shares of 10x GenomicsSEC Form 425 February 2026Class A Common Stock · traded 23 February 2026 · filed 25 February 2026
- ▼ sold on the open market 11,888 shares of 10x GenomicsSEC Form 425 November 2025Class A Common Stock · traded 24 November 2025 · filed 25 November 2025
- ▼ sold on the open market 22,315 shares of 10x GenomicsSEC Form 426 August 2025Class A Common Stock · traded 22 August 2025 · filed 26 August 2025
- ▼ sold on the open market 4,044 shares of 10x GenomicsSEC Form 427 May 2025Class A Common Stock · traded 22 May 2025 · filed 27 May 2025
- was granted 201,704 shares of 10x GenomicsSEC Form 419 March 2025Class A Common Stock · traded 23 October 2024 · filed 19 March 2025
- was granted 133,928 shares of 10x GenomicsSEC Form 419 March 2025Class A Common Stock · traded 17 March 2025 · filed 19 March 2025
- returned to the issuer 185,812 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Stock Option (Right to buy) · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 110,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Stock Option (Right to buy) · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 145,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Stock Option (Right to buy) · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 150,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Stock Option (Right to buy) · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 95,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Stock Option (Right to buy) · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 855,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Stock Option (Right to buy) · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 13,875 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Restricted Stock Unit · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 98,093 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Restricted Stock Unit · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 53,250 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Restricted Stock Unit · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 25,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Restricted Stock Unit · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 592,000 shares of SomaLogic (a derivative holding)SEC Form 49 January 2024Restricted Stock Unit · traded 5 January 2024 · filed 9 January 2024
- returned to the issuer 48,425 shares of SomaLogicSEC Form 49 January 2024Common Stock · traded 5 January 2024 · filed 9 January 2024
- ▼ sold on the open market 1,412 shares of SomaLogicSEC Form 42 October 2023Common Stock · traded 2 March 2023 · filed 2 October 2023
- ▼ sold on the open market 21,584 shares of SomaLogicSEC Form 42 October 2023Common Stock · traded 15 September 2023 · filed 2 October 2023
- was granted 855,000 shares of SomaLogic (a derivative holding)SEC Form 412 June 2023Employee Stock Option (Right to Buy) · traded 8 June 2023 · filed 12 June 2023
- was granted 592,000 shares of SomaLogic (a derivative holding)SEC Form 412 June 2023Restricted Stock Unit (RSU) · traded 8 June 2023 · filed 12 June 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.